The EU is planning to boost biotechnology. A recent report laying out its commitment to the sector won a vote in the European Parliament last week. While the report covered biotechnology as a whole, ...
Positive data from Intra-Cellular Therapies ' latest study could herald further success for the biotechnology stock, according to Canaccord Genuity. The financial firm stood by its buy rating on the ...
MoonLake Immunotherapeutics ' experimental treatment for a chronic skin condition could boost its shares to new heights, according to Goldman Sachs. The bank upgraded the biopharma stock to a buy ...
They don't have any products on the market. They have little or no revenue. Earnings? Nada. Many people are betting that they will fail. And yet they could present some of the best investing ...
Tenaya Therapeutics Inc. (NASDAQ:TNYA) is one of the overlooked growth stocks to buy. On January 8, Morgan Stanley lowered the firm’s price target on Tenaya Therapeutics to $2 from $5 and kept an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results